Navigation Links
Implementing a therapeutic hypothermia program for post-cardiac arrest in acute care hospitals
Date:8/2/2012

New Rochelle, NY, August 2, 2012National guidelines recommend the use of therapeutic hypothermia to improve outcomes in patients who suffer a heart attack outside of a hospital. The results of a survey of all 73 acute care hospitals in New Jersey evaluating the adoption and implementation of this life-saving treatment from 2004-2011 is published in Therapeutic Hypothermia and Temperature Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Therapeutic Hypothermia and Temperature Management website at http://www.liebertpub.com/ther.

Therapeutic hypothermia (TH) involves reducing the body temperature to below normal levels for a prolonged period to minimize the potential damage caused by traumatic or ischemic injury that reduces blood flow to the tissues.

Factors contributing to the initially slow and more recently accelerated implementation of TH in New Jersey hospitals are described by Derek DeLia and colleagues from Rutgers University (New Brunswick, NJ), University of Alabama at Birmingham, Saint Barnabas Medical Center (Livingston, NJ), and Newark Beth Israel Medical Center (Newark, NJ). The authors discuss the wide variation observed in the criteria for patient selection for TH across hospitals and the impact that variations in TH use can have on patient care in the article "Post-Cardiac Arrest Therapeutic Hypothermia in New Jersey Hospitals: Analysis of Adoption and Implementation."

"This communication is important because it focuses on the need of continued adoption and utilization of therapeutic hypothermia targeting cardiac arrest," says W. Dalton Dietrich, PhD, Editor-in-Chief of the Journal and Kinetic Concepts Distinguished Chair in Neurosurgery, Professor of Neurological Surgery, Neurology and Cell Biology and Anatomy, University of Miami Leonard M. Miller School of Medicine. "It is hoped that this journal will continue to provide guidance as more hospitals and treating physicians use this beneficial treatment in limiting the devastating consequences of brain injury."


'/>"/>
Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Related medicine news :

1. New guidelines deliver concise messages for implementing cardiovascular prevention
2. Targeted therapeutics for colon cancer to be presented at AACR meeting
3. The Ludwig Institute for Cancer Research announces launch of iTeos Therapeutics SA
4. 5 more pharmaceutical companies join NIH initiative to speed therapeutic discovery
5. FORMA Therapeutics teams with TGen Drug Development
6. Device implanted in brain has therapeutic potential for Huntingtons disease
7. Enzyme offers new therapeutic target for cancer drugs
8. Lauren Sciences LLCs research team at Ben-Gurion University awarded Campbell Foundation grant to develop a V-Smart therapeutic for neuro-HIV
9. Neurons derived from cord blood cells may represent new therapeutic option
10. Experimental drug may extend therapeutic window for stroke
11. Media alert: 24th EORTC - NCI - AACR Symposium Molecular Targets and Cancer Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Implementing a therapeutic hypothermia program for post-cardiac arrest in acute care hospitals
(Date:1/23/2017)... ... ... Infallible Characteristics of Christ”: a fascinating and entrancing novel exploring the gifts and ... author, Rev. Dr. Robert W. Thomas, the third of seven siblings. He was a ... pastor for over fifteen years. He is a graduate of N.C. College of Theology ...
(Date:1/22/2017)... Frisco, TX (PRWEB) , ... January 22, 2017 , ... ... and provide slow results. Often the results of a simple test will take days ... review. Any Lab Test Now offers customers direct access to their lab tests, bypassing ...
(Date:1/21/2017)... MALO, FRANCE (PRWEB) , ... January 21, 2017 , ... ... of the Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER ... East Africa, Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel Biocare™ dental implant ... media for its creos™ line of bone regenerative products. Specifically, the ... he utilizes creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. ...
(Date:1/20/2017)... ... 2017 , ... Doctor C LLC, a company based out of Arizona that ... continue the marketing and distribution of its product, The Right C. , The Right ... absorption than traditional vitamin C supplements. At the trade show, Doctor C had the ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)...  Ethicon Endo-Surgery, Inc. announced today that ... a privately held medical device company that ... in operating rooms worldwide. The acquisition brings ... devices with Megadyne,s innovative portfolio of electrosurgical ... Ethicon,s goal to deliver the most comprehensive ...
(Date:1/20/2017)... Jan. 20, 2017  Palladian Health, a leading ... the launch of an opioid management program which ... opioids and helps stem the growing tide of ... to treat chronic non-cancer pain (back pain, neck ... and lack of evidence regarding long-term effectiveness. ...
(Date:1/20/2017)... -- Avillion LLP, a co-developer and financier of late-stage ... MD MBA as Chief Medical Officer. Dr Weinberg will be based ... ... spent more than 17 years as a pharmaceutical and biotech executive ... Over the course of his career, he has interfaced with the ...
Breaking Medicine Technology: